{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:05:22Z","timestamp":1793675122303,"version":"4.5.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Minufiya University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00417-026-07170-y","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:16:48Z","timestamp":1774948608000},"page":"2097-2104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autologous platelet-rich plasma versus autologous serum in treatment of dry eye disease"],"prefix":"10.1007","volume":"264","author":[{"given":"Sameh S.","family":"Mandour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Mariey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elgyoshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8841-1151","authenticated-orcid":false,"given":"Ahmed Shebl","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"4","key":"7170_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11882-004-0077-2","volume":"4","author":"PD O'Brien","year":"2004","unstructured":"O\u2019Brien PD, Collum LM (2004) Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep 4(4):314\u20139. https:\/\/doi.org\/10.1007\/s11882-004-0077-2","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"7170_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/ICU.0b013e3283009ef8","volume":"19","author":"GG Quinto","year":"2008","unstructured":"Quinto GG, Camacho W, Behrens A (2008) Postrefractive surgery dry eye. Curr Opin Ophthalmol 19(4):335\u201341. https:\/\/doi.org\/10.1097\/ICU.0b013e3283009ef8","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"7170_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","author":"MA Lemp","year":"2007","unstructured":"Lemp MA, Foulks GN (2007) The definition and classification of dry eye disease. Ocul Surf 5(2):75\u201392","journal-title":"Ocul Surf"},{"key":"7170_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.exer.2015.02.016","volume":"135","author":"E Anitua","year":"2015","unstructured":"Anitua E, de la Fuente M, Muruzabal F, Riestra A, Merayo-Lloves J, Orive G (2015) Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts. Exp Eye Res 135:118\u201326. https:\/\/doi.org\/10.1016\/j.exer.2015.02.016","journal-title":"Exp Eye Res"},{"issue":"7","key":"7170_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00417-004-1106-5","volume":"243","author":"L Liu","year":"2005","unstructured":"Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G (2005) An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 243(7):706\u201314. https:\/\/doi.org\/10.1007\/s00417-004-1106-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"7170_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000100933","volume":"39","author":"JL Alio","year":"2007","unstructured":"Alio JL, Colecha JR, Pastor S, Rodriguez A, Artola A (2007) Symptomatic dry eye treatment with autologous platelet-rich plasma. Ophthalmic Res 39(3):124\u20139. https:\/\/doi.org\/10.1159\/000100933","journal-title":"Ophthalmic Res"},{"issue":"1","key":"7170_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","volume":"128","author":"KL Miller","year":"2010","unstructured":"Miller KL, Walt JG, Mink DR, Satram-Hoang S, Wilson SE, Perry HD, Asbell PA, Pflugfelder SC (2010) Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 128(1):94\u2013101. https:\/\/doi.org\/10.1001\/archophthalmol.2009.356","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"7170_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118(5):615\u201321. https:\/\/doi.org\/10.1001\/archopht.118.5.615","journal-title":"Arch Ophthalmol"},{"issue":"Pt B","key":"7170_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/978-1-4615-0717-8_157","volume":"506","author":"MB Abelson","year":"2002","unstructured":"Abelson MB, Ousler GW, Nally LA, Welch D, Krenzer K (2002) Alternative reference values for tear film break up time in normal and dry eye populations. Adv Exp Med Biol 506(Pt B):1121\u20135. https:\/\/doi.org\/10.1007\/978-1-4615-0717-8_157","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"7170_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0161-6420(99)90170-7","volume":"106","author":"AA Afonso","year":"1999","unstructured":"Afonso AA, Monroy D, Stern ME, Feuer WJ, Tseng SC, Pflugfelder SC (1999) Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology 106(4):803\u201310. https:\/\/doi.org\/10.1016\/S0161-6420(99)90170-7","journal-title":"Ophthalmology"},{"issue":"7","key":"7170_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22(7):640\u201350. https:\/\/doi.org\/10.1097\/00003226-200310000-00008","journal-title":"Cornea"},{"issue":"5","key":"7170_CR12","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.21608\/ejhm.2019.42651","volume":"76","author":"Mohamed Mahmoud Wahdan; Mohamed Mohamed-Aly Ibrahim; Mohammad Farag Abdelsalam Elaraby","year":"2019","unstructured":"Mohamed Mahmoud Wahdan; Mohamed Mohamed-Aly Ibrahim; Mohammad Farag Abdelsalam Elaraby (2019) Assessment of Autologous (Platelet-Rich-Plasma) as A Monotherapy for Treatment of Dry Eye Disease. Egypt J Hosp Med 76(5):4092\u20134098. https:\/\/doi.org\/10.21608\/ejhm.2019.42651","journal-title":"Egypt J Hosp Med"},{"issue":"6","key":"7170_CR13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/ICO.0000000000000109","volume":"33","author":"V Freire","year":"2014","unstructured":"Freire V, Andollo N, Etxebarria J, Hern\u00e1ez-Moya R, Dur\u00e1n JA, Morales MC (2014) Corneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative study. Cornea 33(6):614\u201320. https:\/\/doi.org\/10.1097\/ICO.0000000000000109","journal-title":"Cornea"},{"issue":"7","key":"7170_CR14","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2174\/138920112800624355","volume":"13","author":"JL Alio","year":"2012","unstructured":"Alio JL, Arnalich-Montiel F, Rodriguez AE (2012) The role of \u201ceye platelet rich plasma\u201d (E-PRP) for wound healing in ophthalmology. Curr Pharm Biotechnol 13(7):1257\u201365. https:\/\/doi.org\/10.2174\/138920112800624355","journal-title":"Curr Pharm Biotechnol"},{"issue":"11","key":"7170_CR15","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","volume":"88","author":"G Geerling","year":"2004","unstructured":"Geerling G, Maclennan S, Hartwig D (2004) Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 88(11):1467\u201374. https:\/\/doi.org\/10.1136\/bjo.2004.044347","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"7170_CR16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/bjo.83.4.390","volume":"83","author":"K Tsubota","year":"1999","unstructured":"Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S (1999) Treatment of dry eye by autologous serum application in Sjogren\u2019s syndrome. Br J Ophthalmol 83(4):390\u20135. https:\/\/doi.org\/10.1136\/bjo.83.4.390","journal-title":"Br J Ophthalmol"},{"key":"7170_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009327.pub2","volume":"27;8(8)","author":"Q Pan","year":"2013","unstructured":"Pan Q, Angelina A, Zambrano A, Marrone M, Stark WJ, Heflin T, Tang L, Akpek EK (2013) Autologous serum eye drops for dry eye. Cochrane Database Syst Rev 27;8(8):CD009327. https:\/\/doi.org\/10.1002\/14651858.CD009327.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"7170_CR18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ICO.0000000000000271","volume":"33","author":"M Hussain","year":"2014","unstructured":"Hussain M, Shtein RM, Sugar A, Soong HK, Woodward MA, DeLoss K, Mian SI (2014) Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease. Cornea 33(12):1245\u201351. https:\/\/doi.org\/10.1097\/ICO.0000000000000271","journal-title":"Cornea"},{"issue":"1","key":"7170_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12879-x","volume":"12","author":"C Metheetrairut","year":"2022","unstructured":"Metheetrairut C, Ngowyutagon P, Tunganuntarat A, Khowawisetsut L, Kittisares K, Prabhasawat P (2022) Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease. Sci Rep 12(1):8906. https:\/\/doi.org\/10.1038\/s41598-022-12879-x","journal-title":"Sci Rep"},{"issue":"9","key":"7170_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093126","volume":"12","author":"D Wr\u00f3bel-Dudzi\u0144ska","year":"2023","unstructured":"Wr\u00f3bel-Dudzi\u0144ska D, Przekora A, Kazimierczak P, \u0106wikli\u0144ska-Haszcz A, Kosior-Jarecka E, \u017barnowski T (2023) The comparison between the composition of 100% autologous serum and 100% platelet-rich plasma eye drops and their impact on the treatment effectiveness of dry eye disease in primary Sjogren syndrome. J Clin Med 12(9):3126. https:\/\/doi.org\/10.3390\/jcm12093126","journal-title":"J Clin Med"},{"issue":"2","key":"7170_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40123-017-0100-z","volume":"6","author":"JL Alio","year":"2017","unstructured":"Alio JL, Rodriguez AE, Ferreira-Oliveira R, Wr\u00f3bel-Dudzi\u0144ska D, Abdelghany AA (2017) Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study. Ophthalmol Ther 6(2):285\u2013293. https:\/\/doi.org\/10.1007\/s40123-017-0100-z","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"7170_CR22","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1111\/aos.13907","volume":"97","author":"V Garc\u00eda-Conca","year":"2019","unstructured":"Garc\u00eda-Conca V, Abad-Collado M, Hueso-Abancens JR, Mengual-Verd\u00fa E, Pi\u00f1ero DP, Aguirre-Balsalobre F, Molina JC (2019) Efficacy and safety of treatment of hyposecretory dry eye with platelet-rich plasma. Acta Ophthalmol 97(2):e170\u2013e178. https:\/\/doi.org\/10.1111\/aos.13907","journal-title":"Acta Ophthalmol"},{"key":"7170_CR23","unstructured":"Ribeiro MVMR, Barbosa (2016) Fabiano Timb\u00f3 and Ribeiro, Luiz Eduardo Feliciano and Lacet, Celina Maria Costa and Lyra, Jo\u00e3o Marcelo de Almeida Gusm\u00e3o and Guedes, Ver\u00f4nica de Lima and Pinto, Patr\u00edcia Costa Alves and Ribeiro, Eurica Ad\u00e9lia Nogueira. Plasma rico em plaquetas no olho seco diab\u00e9tico. Rev Bras Oftalmol. [online]. vol. 75, n. 4, [cited 2025-05-27], pp.308\u2013313. Available from: <https:\/\/www.rbojournal.org\/article\/plasma-rico-em-plaquetas-no-olho-seco-diabetico\/. ISSN 0034-7280"},{"issue":"2","key":"7170_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","volume":"139","author":"T Kojima","year":"2005","unstructured":"Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, Tsubota K (2005) The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 139(2):242\u20136. https:\/\/doi.org\/10.1016\/j.ajo.2004.08.040","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"7170_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/bjo.2003.026211","volume":"88","author":"BA Noble","year":"2004","unstructured":"Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, Burr J, Stewart O, Quereshi S (2004) Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 88(5):647\u201352. https:\/\/doi.org\/10.1136\/bjo.2003.026211","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"7170_CR26","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3109\/02713683.2012.674609","volume":"37","author":"CA Urzua","year":"2012","unstructured":"Urzua CA, Vasquez DH, Huidobro A, Hernandez H, Alfaro J (2012) Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. Curr Eye Res 37(8):684\u20138. https:\/\/doi.org\/10.3109\/02713683.2012.674609","journal-title":"Curr Eye Res"},{"issue":"1","key":"7170_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/02713683.2012.720340","volume":"38","author":"YK Cho","year":"2013","unstructured":"Cho YK, Huang W, Kim GY, Lim BS (2013) Comparison of autologous serum eye drops with different diluents. Curr Eye Res 38(1):9\u201317. https:\/\/doi.org\/10.3109\/02713683.2012.720340","journal-title":"Curr Eye Res"},{"issue":"1","key":"7170_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2024-001857","volume":"9","author":"P Jongkhajornpong","year":"2024","unstructured":"Jongkhajornpong P, Lekhanont K, Rattanasiri S, Numthavaj P, McKay G, Attia J, Thakkinstian A (2024) Efficacy of 100% autologous platelet-rich plasma and 100% autologous serum in dry eye disease: a randomised controlled trial. BMJ Open Ophthalmol 9(1):e001857. https:\/\/doi.org\/10.1136\/bmjophth-2024-001857","journal-title":"BMJ Open Ophthalmol"},{"issue":"1","key":"7170_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46671-2","volume":"13","author":"MJ Kang","year":"2023","unstructured":"Kang MJ, Lee JH, Hwang J, Chung SH (2023) Efficacy and safety of platelet-rich plasma and autologous-serum eye drops for dry eye in primary Sj\u00f6gren\u2019s syndrome: a randomized trial. Sci Rep 13(1):19279. https:\/\/doi.org\/10.1038\/s41598-023-46671-2","journal-title":"Sci Rep"},{"issue":"6","key":"7170_CR30","doi-asserted-by":"publisher","first-page":"102247","DOI":"10.1016\/j.clae.2024.102247","volume":"47","author":"\u0130 \u00d6zl\u00fck","year":"2024","unstructured":"\u00d6zl\u00fck \u0130, Y\u00fcksel B, K\u00fcsbeci T (2024) Comparison of autologous serum and platelet-rich plasma in the treatment of severe dry eye and persistent epithelial defects. Cont Lens Anterior Eye 47(6):102247. https:\/\/doi.org\/10.1016\/j.clae.2024.102247Epub 2024 Jun 4. PMID: 38834425","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"7170_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/ICO.0000000000000016","volume":"33","author":"MY Avila","year":"2014","unstructured":"Avila MY (2014) Restoration of human lacrimal function following platelet-rich plasma injection. Cornea 33(1):18\u201321. https:\/\/doi.org\/10.1097\/ICO.0000000000000016","journal-title":"Cornea"},{"issue":"9","key":"7170_CR32","first-page":"6742","volume":"60","author":"M Passilongo","year":"2019","unstructured":"Passilongo M, Bergamo L, Romanelli F, Lovisi A, Colosio M (2019) Comparison between homologous serum eye drops and platelet-rich plasma eye drops as treatment for dry eye disease. Invest Ophthalmol Vis Sci 60(9):6742","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"7170_CR33","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/archophthalmol.2012.1652","volume":"130","author":"CA Dalmon","year":"2012","unstructured":"Dalmon CA, Chandra NS, Jeng BH (2012) Use of autologous serum eyedrops for the treatment of ocular surface disease: first US experience in a large population as an insurance-covered benefit. Arch Ophthalmol 130(12):1612\u20133. https:\/\/doi.org\/10.1001\/archophthalmol.2012.1652","journal-title":"Arch Ophthalmol"},{"key":"7170_CR34","doi-asserted-by":"crossref","unstructured":"Sadeghi J, Ghavidel Yazdi S, Hajali V, Forouzanfar F, Moghbeli M, Arabi K, Saburi E (2025) New Methods in Dry Eye Treatment: Platelet-Rich Plasma. J Ocul Pharmacol Ther. Oct 24","DOI":"10.1177\/10807683251390240"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07170-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07170-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07170-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:48:15Z","timestamp":1783403295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07170-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7170"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07170-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the Menoufia University Faculty of Medicine Research Ethics Committee and with the 1964 Helsinki declaration and its later amendments. The study was approved by the Menoufia University Faculty of Medicine Research Ethics Committee Institutional Review Board (IRB approval number and date: 7\/2020 OPHT15).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}